Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap

Although low-density lipoprotein cholesterol lowering is effective in atherosclerotic cardiovascular disease (ASCVD) prevention, considerable ‘lipid-associated’ residual risk remains, particularly in patients with mild-to-moderate hypertriglyceridaemia (2–10 mmol/L; 176–880 mg/dL). Triglyceride (TG)...

Descripción completa

Detalles Bibliográficos
Autores principales: Parhofer, Klaus G, Chapman, M John, Nordestgaard, Børge G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537801/
https://www.ncbi.nlm.nih.gov/pubmed/33061865
http://dx.doi.org/10.1093/eurheartj/suaa116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537801/
https://www.ncbi.nlm.nih.gov/pubmed/33061865
http://dx.doi.org/10.1093/eurheartj/suaa116

Ejemplares similares